Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors

Scand J Rheumatol. 2003;32(1):19-24. doi: 10.1080/03009740310000355.

Abstract

Objective: To investigate the endogenous regulation of interleukin-1 (IL-1) cytokine network in osteoarthritic (OA) and rheumatoid (RA) cartilage in relation to nitric oxide (NO) production.

Methods: Cartilage specimen obtained from OA and RA patients undergoing knee replacement surgery were studied for iNOS expression, NO and IL-1 antagonist production in tissue culture.

Results: OA cartilage responded to IL-1beta-stimulation with higher NO production than RA cartilage, whereas there was no difference in NO synthesis between OA and RA samples when stimulated by TNFalpha or LPS. Interleukin-1 receptor antagonist (IL-1Ra) production was higher in RA cartilage than in OA cartilage, and its production was increased by NO synthase inhibitor 1400W.

Conclusion: IL-1beta is a potent stimulator of NO production by the iNOS pathway in RA and more pronouncedly in OA cartilage. This process is regulated by cartilage derived IL-1 antagonists, and is implicated in cartilage destruction and synovial inflammation in OA and RA joints.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amidines / pharmacology
  • Antibodies, Blocking / pharmacology
  • Arthritis, Rheumatoid / metabolism*
  • Benzylamines / pharmacology
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / metabolism*
  • Culture Techniques
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / immunology
  • Interleukin-1 / pharmacology
  • Lipopolysaccharides / pharmacology
  • Middle Aged
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type II
  • Osteoarthritis, Knee / metabolism*
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Amidines
  • Antibodies, Blocking
  • Benzylamines
  • Enzyme Inhibitors
  • Interleukin-1
  • Lipopolysaccharides
  • N-(3-(aminomethyl)benzyl)acetamidine
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II